Structure

Physi-Chem Properties

Molecular Weight:  592.22
Volume:  569.095
LogP:  1.651
LogD:  0.733
LogS:  -2.896
# Rotatable Bonds:  11
TPSA:  204.83
# H-Bond Aceptor:  13
# H-Bond Donor:  7
# Rings:  4
# Heavy Atoms:  13

MedChem Properties

QED Drug-Likeness Score:  0.138
Synthetic Accessibility Score:  4.515
Fsp3:  0.483
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.381
MDCK Permeability:  3.21312400046736e-05
Pgp-inhibitor:  0.006
Pgp-substrate:  0.997
Human Intestinal Absorption (HIA):  0.953
20% Bioavailability (F20%):  0.776
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.053
Plasma Protein Binding (PPB):  93.2682113647461%
Volume Distribution (VD):  0.287
Pgp-substrate:  5.786600589752197%

ADMET: Metabolism

CYP1A2-inhibitor:  0.059
CYP1A2-substrate:  0.027
CYP2C19-inhibitor:  0.167
CYP2C19-substrate:  0.078
CYP2C9-inhibitor:  0.233
CYP2C9-substrate:  0.838
CYP2D6-inhibitor:  0.025
CYP2D6-substrate:  0.213
CYP3A4-inhibitor:  0.056
CYP3A4-substrate:  0.044

ADMET: Excretion

Clearance (CL):  0.807
Half-life (T1/2):  0.71

ADMET: Toxicity

hERG Blockers:  0.416
Human Hepatotoxicity (H-HT):  0.082
Drug-inuced Liver Injury (DILI):  0.029
AMES Toxicity:  0.309
Rat Oral Acute Toxicity:  0.283
Maximum Recommended Daily Dose:  0.013
Skin Sensitization:  0.963
Carcinogencity:  0.115
Eye Corrosion:  0.003
Eye Irritation:  0.062
Respiratory Toxicity:  0.034

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC235294

Natural Product ID:  NPC235294
Common Name*:   Osmanthuside B6
IUPAC Name:   [(2R,3R,4S,5R,6R)-3,5-dihydroxy-6-[2-(4-hydroxyphenyl)ethoxy]-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate
Synonyms:   Osmanthuside B6
Standard InCHIKey:  NACKALNITXFLJE-KWZXHGFLSA-N
Standard InCHI:  InChI=1S/C29H36O13/c1-15-22(33)24(35)25(36)29(40-15)42-27-23(34)20(14-39-21(32)11-6-16-2-7-18(30)8-3-16)41-28(26(27)37)38-13-12-17-4-9-19(31)10-5-17/h2-11,15,20,22-31,33-37H,12-14H2,1H3/b11-6+/t15-,20+,22-,23+,24+,25+,26+,27-,28+,29-/m0/s1
SMILES:  C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@H]1[C@@H]([C@@H](COC(=O)/C=C/c2ccc(cc2)O)O[C@H]([C@@H]1O)OCCc1ccc(cc1)O)O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL449440
PubChem CID:   10054173
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000476] Cinnamic acids and derivatives
        • [CHEMONTID:0001391] Hydroxycinnamic acids and derivatives
          • [CHEMONTID:0003002] Hydroxycinnamic acid esters
            • [CHEMONTID:0000465] Coumaric acid esters

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO2726 Ligustrum robustum Species Oleaceae Eukaryota leaves n.a. n.a. PMID[12828473]
NPO10680 Cistanche deserticola Species Orobanchaceae Eukaryota n.a. n.a. n.a. PMID[25900014]
NPO10680 Cistanche deserticola Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO2726 Ligustrum robustum Species Oleaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO10680 Cistanche deserticola Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO10680 Cistanche deserticola Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO10680 Cistanche deserticola Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO10680 Cistanche deserticola Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 91700.0 nM PMID[473160]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC235294 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC46137
0.984 High Similarity NPC246869
0.984 High Similarity NPC225384
0.984 High Similarity NPC138777
0.9688 High Similarity NPC263829
0.9677 High Similarity NPC288416
0.9528 High Similarity NPC478255
0.952 High Similarity NPC106677
0.9466 High Similarity NPC472350
0.9466 High Similarity NPC64141
0.9466 High Similarity NPC81515
0.9466 High Similarity NPC68092
0.9466 High Similarity NPC476383
0.9466 High Similarity NPC89105
0.9466 High Similarity NPC197316
0.9444 High Similarity NPC225307
0.944 High Similarity NPC471157
0.9389 High Similarity NPC260425
0.936 High Similarity NPC83218
0.936 High Similarity NPC126991
0.9323 High Similarity NPC47471
0.9323 High Similarity NPC134405
0.9323 High Similarity NPC476377
0.9323 High Similarity NPC476385
0.9318 High Similarity NPC205195
0.9274 High Similarity NPC52097
0.9254 High Similarity NPC222433
0.9254 High Similarity NPC265648
0.9248 High Similarity NPC475530
0.9248 High Similarity NPC473799
0.9242 High Similarity NPC78363
0.9231 High Similarity NPC28637
0.9213 High Similarity NPC471882
0.9213 High Similarity NPC156692
0.9213 High Similarity NPC173150
0.9213 High Similarity NPC35288
0.9213 High Similarity NPC45224
0.9213 High Similarity NPC471881
0.9194 High Similarity NPC11724
0.9185 High Similarity NPC96795
0.9185 High Similarity NPC476378
0.9185 High Similarity NPC264632
0.9185 High Similarity NPC476397
0.9185 High Similarity NPC269141
0.9185 High Similarity NPC476375
0.9185 High Similarity NPC76406
0.9185 High Similarity NPC112
0.9185 High Similarity NPC476381
0.9185 High Similarity NPC298257
0.9185 High Similarity NPC175214
0.9185 High Similarity NPC119537
0.9185 High Similarity NPC247032
0.9185 High Similarity NPC476380
0.9185 High Similarity NPC476384
0.9185 High Similarity NPC205864
0.916 High Similarity NPC886
0.916 High Similarity NPC34293
0.916 High Similarity NPC287597
0.9134 High Similarity NPC61181
0.9134 High Similarity NPC252114
0.9118 High Similarity NPC196063
0.9118 High Similarity NPC64195
0.9118 High Similarity NPC296954
0.9118 High Similarity NPC300894
0.9118 High Similarity NPC141455
0.9113 High Similarity NPC476872
0.9098 High Similarity NPC65262
0.9098 High Similarity NPC101686
0.9098 High Similarity NPC476376
0.9098 High Similarity NPC469364
0.9062 High Similarity NPC103533
0.9051 High Similarity NPC100998
0.9051 High Similarity NPC34587
0.9051 High Similarity NPC34927
0.9051 High Similarity NPC476382
0.9051 High Similarity NPC252292
0.9044 High Similarity NPC105005
0.904 High Similarity NPC55608
0.903 High Similarity NPC328273
0.903 High Similarity NPC171134
0.903 High Similarity NPC321638
0.903 High Similarity NPC321184
0.9023 High Similarity NPC471345
0.9015 High Similarity NPC169398
0.9008 High Similarity NPC473285
0.8986 High Similarity NPC229505
0.896 High Similarity NPC201402
0.896 High Similarity NPC469703
0.896 High Similarity NPC160854
0.896 High Similarity NPC469704
0.8947 High Similarity NPC476870
0.8923 High Similarity NPC253595
0.8921 High Similarity NPC232992
0.8905 High Similarity NPC204644
0.8889 High Similarity NPC469686
0.8881 High Similarity NPC166180
0.8832 High Similarity NPC140502
0.8819 High Similarity NPC471067
0.8794 High Similarity NPC473427
0.8794 High Similarity NPC259347
0.8794 High Similarity NPC306890
0.8794 High Similarity NPC476386
0.8794 High Similarity NPC94871
0.8794 High Similarity NPC471062
0.8794 High Similarity NPC470933
0.8794 High Similarity NPC476398
0.8788 High Similarity NPC281798
0.8788 High Similarity NPC254819
0.8779 High Similarity NPC229784
0.8779 High Similarity NPC477294
0.8779 High Similarity NPC477293
0.8768 High Similarity NPC478250
0.8768 High Similarity NPC40305
0.875 High Similarity NPC232454
0.875 High Similarity NPC470907
0.875 High Similarity NPC178449
0.8741 High Similarity NPC472132
0.8732 High Similarity NPC470934
0.8732 High Similarity NPC257970
0.8732 High Similarity NPC470927
0.8732 High Similarity NPC188393
0.8731 High Similarity NPC471883
0.873 High Similarity NPC469702
0.873 High Similarity NPC282409
0.8722 High Similarity NPC254275
0.8714 High Similarity NPC476865
0.871 High Similarity NPC148055
0.8705 High Similarity NPC471028
0.8705 High Similarity NPC476867
0.8702 High Similarity NPC232880
0.8696 High Similarity NPC148080
0.8696 High Similarity NPC469623
0.8661 High Similarity NPC476445
0.8661 High Similarity NPC469548
0.8661 High Similarity NPC476448
0.8657 High Similarity NPC254398
0.8652 High Similarity NPC97240
0.8647 High Similarity NPC219677
0.8643 High Similarity NPC476864
0.8643 High Similarity NPC476869
0.8643 High Similarity NPC476866
0.8643 High Similarity NPC226722
0.8643 High Similarity NPC476868
0.8636 High Similarity NPC469549
0.8636 High Similarity NPC184092
0.8636 High Similarity NPC295970
0.8633 High Similarity NPC478239
0.8633 High Similarity NPC293154
0.8626 High Similarity NPC476873
0.8623 High Similarity NPC186406
0.8613 High Similarity NPC49597
0.8611 High Similarity NPC106818
0.8601 High Similarity NPC182350
0.8582 High Similarity NPC473924
0.8582 High Similarity NPC212808
0.8571 High Similarity NPC184464
0.8571 High Similarity NPC251062
0.8571 High Similarity NPC469705
0.8571 High Similarity NPC470122
0.8571 High Similarity NPC110063
0.8571 High Similarity NPC296659
0.8571 High Similarity NPC17968
0.8571 High Similarity NPC202391
0.8561 High Similarity NPC145319
0.8561 High Similarity NPC296643
0.8561 High Similarity NPC157816
0.856 High Similarity NPC175771
0.8552 High Similarity NPC87403
0.8548 High Similarity NPC157338
0.8548 High Similarity NPC313193
0.8531 High Similarity NPC106138
0.8527 High Similarity NPC476142
0.8521 High Similarity NPC175275
0.8519 High Similarity NPC114116
0.8516 High Similarity NPC229600
0.8511 High Similarity NPC287615
0.8511 High Similarity NPC83743
0.8511 High Similarity NPC216819
0.8511 High Similarity NPC138915
0.8511 High Similarity NPC262182
0.85 High Similarity NPC469367
0.8485 Intermediate Similarity NPC469687
0.8485 Intermediate Similarity NPC108659
0.8485 Intermediate Similarity NPC79715
0.8485 Intermediate Similarity NPC264900
0.8485 Intermediate Similarity NPC231607
0.8483 Intermediate Similarity NPC478268
0.8478 Intermediate Similarity NPC31745
0.8478 Intermediate Similarity NPC220936
0.8467 Intermediate Similarity NPC157554
0.8462 Intermediate Similarity NPC473138
0.8462 Intermediate Similarity NPC3460
0.8462 Intermediate Similarity NPC300262
0.8462 Intermediate Similarity NPC28776
0.8462 Intermediate Similarity NPC210611
0.8462 Intermediate Similarity NPC28651
0.8462 Intermediate Similarity NPC192763
0.8462 Intermediate Similarity NPC261122
0.8462 Intermediate Similarity NPC23677
0.8462 Intermediate Similarity NPC220282

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC235294 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9466 High Similarity NPD7266 Discontinued
0.7785 Intermediate Similarity NPD1653 Approved
0.7763 Intermediate Similarity NPD8455 Phase 2
0.7761 Intermediate Similarity NPD1091 Approved
0.774 Intermediate Similarity NPD6190 Approved
0.7727 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7622 Intermediate Similarity NPD4978 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD7054 Approved
0.75 Intermediate Similarity NPD7097 Phase 1
0.7485 Intermediate Similarity NPD7685 Pre-registration
0.7469 Intermediate Similarity NPD7472 Approved
0.7469 Intermediate Similarity NPD7074 Phase 3
0.7453 Intermediate Similarity NPD7228 Approved
0.7432 Intermediate Similarity NPD4628 Phase 3
0.7378 Intermediate Similarity NPD7251 Discontinued
0.7365 Intermediate Similarity NPD1652 Phase 2
0.7361 Intermediate Similarity NPD4340 Discontinued
0.7353 Intermediate Similarity NPD5126 Approved
0.7353 Intermediate Similarity NPD5125 Phase 3
0.7343 Intermediate Similarity NPD6233 Phase 2
0.7338 Intermediate Similarity NPD4380 Phase 2
0.7333 Intermediate Similarity NPD7808 Phase 3
0.7333 Intermediate Similarity NPD9545 Approved
0.7328 Intermediate Similarity NPD969 Suspended
0.7324 Intermediate Similarity NPD3027 Phase 3
0.7317 Intermediate Similarity NPD6797 Phase 2
0.7289 Intermediate Similarity NPD8312 Approved
0.7289 Intermediate Similarity NPD8313 Approved
0.7287 Intermediate Similarity NPD1358 Approved
0.7285 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD7075 Discontinued
0.7273 Intermediate Similarity NPD6559 Discontinued
0.7241 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD5124 Phase 1
0.7229 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD5058 Phase 3
0.7215 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7172 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7172 Intermediate Similarity NPD1613 Approved
0.7153 Intermediate Similarity NPD3764 Approved
0.7153 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7153 Intermediate Similarity NPD6798 Discontinued
0.7143 Intermediate Similarity NPD5403 Approved
0.7143 Intermediate Similarity NPD7843 Approved
0.7134 Intermediate Similarity NPD3818 Discontinued
0.7134 Intermediate Similarity NPD37 Approved
0.7133 Intermediate Similarity NPD6674 Discontinued
0.7133 Intermediate Similarity NPD4908 Phase 1
0.7125 Intermediate Similarity NPD6234 Discontinued
0.7122 Intermediate Similarity NPD422 Phase 1
0.7107 Intermediate Similarity NPD4965 Approved
0.7107 Intermediate Similarity NPD4966 Approved
0.7107 Intermediate Similarity NPD4967 Phase 2
0.7101 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7097 Intermediate Similarity NPD2933 Approved
0.7097 Intermediate Similarity NPD2934 Approved
0.7093 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7089 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD8166 Discontinued
0.7077 Intermediate Similarity NPD3134 Approved
0.7066 Intermediate Similarity NPD7240 Approved
0.7055 Intermediate Similarity NPD4060 Phase 1
0.7051 Intermediate Similarity NPD7458 Discontinued
0.704 Intermediate Similarity NPD2859 Approved
0.704 Intermediate Similarity NPD2860 Approved
0.7034 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7027 Intermediate Similarity NPD4536 Approved
0.7027 Intermediate Similarity NPD4538 Approved
0.7027 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7025 Intermediate Similarity NPD6801 Discontinued
0.7021 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.702 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7015 Intermediate Similarity NPD5535 Approved
0.7013 Intermediate Similarity NPD5401 Approved
0.7007 Intermediate Similarity NPD230 Phase 1
0.7007 Intermediate Similarity NPD6355 Discontinued
0.6986 Remote Similarity NPD4062 Phase 3
0.6985 Remote Similarity NPD7157 Approved
0.698 Remote Similarity NPD7033 Discontinued
0.6972 Remote Similarity NPD3225 Approved
0.697 Remote Similarity NPD2684 Approved
0.6966 Remote Similarity NPD7095 Approved
0.6962 Remote Similarity NPD7411 Suspended
0.6957 Remote Similarity NPD1548 Phase 1
0.6948 Remote Similarity NPD6799 Approved
0.6944 Remote Similarity NPD2861 Phase 2
0.6939 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6937 Remote Similarity NPD5402 Approved
0.6923 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6909 Remote Similarity NPD6166 Phase 2
0.6909 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6909 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6905 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6903 Remote Similarity NPD3536 Discontinued
0.6903 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6897 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6879 Remote Similarity NPD1610 Phase 2
0.6879 Remote Similarity NPD3705 Approved
0.6875 Remote Similarity NPD3020 Approved
0.6867 Remote Similarity NPD5960 Phase 3
0.6867 Remote Similarity NPD5588 Approved
0.6863 Remote Similarity NPD3750 Approved
0.6863 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6857 Remote Similarity NPD5238 Clinical (unspecified phase)
0.6846 Remote Similarity NPD6653 Approved
0.6842 Remote Similarity NPD1549 Phase 2
0.6829 Remote Similarity NPD7199 Phase 2
0.6828 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6828 Remote Similarity NPD5736 Approved
0.6821 Remote Similarity NPD2935 Discontinued
0.6813 Remote Similarity NPD1934 Approved
0.6812 Remote Similarity NPD694 Clinical (unspecified phase)
0.6809 Remote Similarity NPD3496 Discontinued
0.6809 Remote Similarity NPD3847 Discontinued
0.6806 Remote Similarity NPD2797 Approved
0.6806 Remote Similarity NPD3094 Phase 2
0.6797 Remote Similarity NPD5698 Clinical (unspecified phase)
0.6791 Remote Similarity NPD3021 Approved
0.6791 Remote Similarity NPD3022 Approved
0.679 Remote Similarity NPD7768 Phase 2
0.6786 Remote Similarity NPD1357 Approved
0.6786 Remote Similarity NPD5844 Phase 1
0.6782 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6781 Remote Similarity NPD6832 Phase 2
0.6779 Remote Similarity NPD1933 Approved
0.6776 Remote Similarity NPD5763 Approved
0.6776 Remote Similarity NPD5762 Approved
0.6776 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6776 Remote Similarity NPD1552 Clinical (unspecified phase)
0.677 Remote Similarity NPD2393 Clinical (unspecified phase)
0.677 Remote Similarity NPD7819 Suspended
0.6767 Remote Similarity NPD290 Approved
0.6761 Remote Similarity NPD1535 Discovery
0.6758 Remote Similarity NPD8320 Phase 1
0.6758 Remote Similarity NPD8319 Approved
0.6752 Remote Similarity NPD7314 Clinical (unspecified phase)
0.675 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6739 Remote Similarity NPD4198 Discontinued
0.6738 Remote Similarity NPD5846 Approved
0.6738 Remote Similarity NPD6516 Phase 2
0.6736 Remote Similarity NPD8651 Approved
0.6735 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6732 Remote Similarity NPD2424 Discontinued
0.673 Remote Similarity NPD3455 Phase 2
0.6728 Remote Similarity NPD3817 Phase 2
0.6728 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6727 Remote Similarity NPD8127 Discontinued
0.6726 Remote Similarity NPD3751 Discontinued
0.6714 Remote Similarity NPD1894 Discontinued
0.6713 Remote Similarity NPD1481 Phase 2
0.6704 Remote Similarity NPD7700 Phase 2
0.6704 Remote Similarity NPD7699 Phase 2
0.6703 Remote Similarity NPD7435 Discontinued
0.6692 Remote Similarity NPD968 Approved
0.6691 Remote Similarity NPD9493 Approved
0.6689 Remote Similarity NPD3268 Approved
0.6688 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6687 Remote Similarity NPD6599 Discontinued
0.6667 Remote Similarity NPD2029 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7237 Clinical (unspecified phase)
0.6667 Remote Similarity NPD4659 Approved
0.6667 Remote Similarity NPD8150 Discontinued
0.6667 Remote Similarity NPD1465 Phase 2
0.6667 Remote Similarity NPD7440 Discontinued
0.6649 Remote Similarity NPD7585 Approved
0.6647 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6645 Remote Similarity NPD1510 Phase 2
0.6645 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6645 Remote Similarity NPD4108 Discontinued
0.6644 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6644 Remote Similarity NPD6663 Approved
0.6643 Remote Similarity NPD5536 Phase 2
0.6643 Remote Similarity NPD3092 Approved
0.6642 Remote Similarity NPD9265 Clinical (unspecified phase)
0.6641 Remote Similarity NPD940 Approved
0.6641 Remote Similarity NPD846 Approved
0.6629 Remote Similarity NPD6534 Approved
0.6629 Remote Similarity NPD6535 Approved
0.662 Remote Similarity NPD4626 Approved
0.6617 Remote Similarity NPD5048 Discontinued
0.6613 Remote Similarity NPD8151 Discontinued
0.6612 Remote Similarity NPD7680 Approved
0.6607 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6601 Remote Similarity NPD1551 Phase 2
0.66 Remote Similarity NPD4140 Approved
0.66 Remote Similarity NPD1240 Approved
0.6595 Remote Similarity NPD7583 Approved
0.6591 Remote Similarity NPD6647 Phase 2
0.6588 Remote Similarity NPD8470 Clinical (unspecified phase)
0.6587 Remote Similarity NPD3787 Discontinued
0.6582 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6582 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6575 Remote Similarity NPD4103 Phase 2
0.6575 Remote Similarity NPD1203 Approved
0.6575 Remote Similarity NPD4104 Clinical (unspecified phase)
0.6575 Remote Similarity NPD6362 Approved
0.6569 Remote Similarity NPD228 Approved
0.6565 Remote Similarity NPD3028 Approved
0.6565 Remote Similarity NPD1242 Phase 1

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data